2-74461391-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_006302.3(MOGS):c.2398C>T(p.Gln800*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006302.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
MOGS-congenital disorder of glycosylation Uncertain:1
This variant has not been reported in the literature in individuals with MOGS-related conditions. This sequence change results in a premature translational stop signal in the MOGS gene (p.Gln800*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 38 amino acids of the MOGS protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant disrupts a region of the protein in which other variant(s) (p.Thr802Ile) have been observed in individuals with MOGS-related conditions (PMID: 29235540). This suggests that this may be a clinically significant region of the MOGS protein. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at